Supplementary Table S3 from Undermining Glutaminolysis Bolsters Chemotherapy While NRF2 Promotes Chemoresistance in KRAS-Driven Pancreatic CancersSuman Mukhopadhyay,Debanjan Goswami,Pavan P. Adiseshaiah,William Burgan,Ming Yi,Theresa M. Guerin,Serguei V. Kozlov,Dwight V. Nissley,Frank McCormickcrossref（2023）被引用0|浏览0摘要Metabolic Pathway Enrichment in PDAC Patients Treated with Gemcitabine (Data Pooled from TCGA)更多查看译文上传PDF原文链接分享引用加入学术空间AI Read Science数据免责声明页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cnChat Paper正在生成论文摘要
原文链接
分享
引用
